Home > Report on the risk assessment of 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45) in the framework of the Council Decision on new psychoactive substances.

European Monitoring Centre for Drugs and Drug Addiction. (2015) Report on the risk assessment of 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45) in the framework of the Council Decision on new psychoactive substances. Office for Official Publications of the European Communities.

[img]
Preview
PDF (Full report) - Published Version
709kB

This publication presents the data and findings of the risk assessment on MT-45 (1-cyclohexyl-4-(1, 2-diphenylethyl)piperazine), carried out by the extended Scientific Committee of the EMCDDA on 16 September 2014. The main part of the publication, the Risk Assessment Report, examines the health and social risks of the drug, information on international trafficking and the involvement of organised crime, and the potential implications of subjecting the drug to control measures. On the basis of this report the Council decided on 8 October 2015 that MT-45 should be subject to control measures across the Member States.


Date:2015
Pages:48 p.
Publisher:Office for Official Publications of the European Communities
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction
EndNote:View
Accession Number:HRB (Electronic Only)
Subjects:A Substance use, abuse, and dependence > Effects and consequences
B Substances > New (novel) psychoactive substances
VA Geographic area > Europe

Repository Staff Only: item control page